What Is a Meningioma and Why Are Most Benign?
A meningioma arises from outside the brain tissue (extra-axial), not within it; it develops from the arachnoid cells of the covering membrane and forms a broad-based attachment to the dura. About 80-85% of cases are benign (WHO grade 1), while a smaller proportion behave atypically (grade 2) or malignantly (grade 3). It is roughly twice as common in women as in men, its frequency rises with age, and it usually grows slowly. Because the tumor tends to push the brain aside slowly rather than infiltrate it, the surgical margin in the right patient is often clearer; this is one of the factors that make long-term outcomes favorable in benign meningioma.
Symptoms and Diagnosis
Because meningiomas grow slowly, symptoms are insidious and progressive and depend on tumor location: site-specific headache, epileptic seizures, limb weakness or sensory loss in the compressed area, visual problems, loss of smell, and personality changes with frontal location can occur. A substantial proportion of cases cause no symptoms. Contrast-enhanced brain MRI is the gold standard for diagnosis; a meningioma typically appears as a broad-based, strongly and homogeneously enhancing mass with a 'tail sign' in the adjacent dura. CT reveals calcification and bone thickening. Definitive diagnosis can only be made by pathological examination of tissue obtained at surgery.
Not Every Meningioma Requires Surgery
The treatment decision is made individually according to tumor size, location, growth rate, symptoms and the patient's general condition. For a small, asymptomatic meningioma—especially one found in an older patient—the most appropriate approach is often active surveillance (watch-and-wait) with periodic MRI; not every tumor needs immediate intervention. For symptomatic, growing or compressing tumors, the goal is the widest safe surgical resection. For deep-seated or small-to-moderate tumors not suited to surgery, stereotactic radiosurgery (Gamma Knife, CyberKnife) is an effective option. Which path is chosen is determined by multidisciplinary evaluation; our aim is to offer each patient not 'an operation' but what is most appropriate for them.
The Surgical Process and Recovery
In patients planned for surgery, preparation includes a detailed neurological examination, contrast MRI, vascular imaging when needed, and an anaesthetic assessment. In surgery the patient is positioned according to the tumor location, a shave as narrow as possible within the hairline is sufficient, the bone flap is removed, and the tumor is removed under the microscope with navigation guidance. The broadly attached dura is also cleared when needed. The procedure takes a time that varies with the location and size of the tumor. Afterwards there is usually a day of intensive care followed by a few days in hospital; the extent of resection is assessed with a control MRI, and radiotherapy is planned according to the pathology result if needed.
Risks and Realistic Expectations
Meningioma surgery is major surgery, and its risks must be discussed honestly: bleeding, infection, a temporary or permanent neurological deficit depending on tumor location, brain swelling lasting a few days and the risk of seizures can be listed. These rates vary with the location and size of the tumor, the patient's age and accompanying conditions; an experienced team and correct patient selection reduce these risks. In benign (grade 1) meningioma, long-term outcomes after complete removal are usually good with a low recurrence risk; in atypical and malignant tumors the recurrence risk is higher and follow-up is closer. We do not promise a guaranteed result; expectations are shared openly before surgery.